BNT162b2 is a lipid nanoparticle鈥揻ormulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. The primary end points were efficacy of the vaccine against laboratory-confirmed Covid-19 and safety. Results A total of 4...
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603-2615. doi:10.1056/NEJMoa2034577PubMedGoogle ScholarCrossref 10. Baden LR, El Sahly HM, Essink B, et al; COVE Study Group. Efficacy and safety of the mRNA-1273 SARS-CoV-2...
Immunogenicity and Safety of BNT162b2mRNAVaccine in Chinese Adults: A Randomized Clinical Trial35 Pages Posted: 19 May 2022 10号通过临床,19号论文投稿,实际上1月份结束。这里你说没有认为控制,我不信。是不是等ARCoV就不知道了。 2022-05-29 18:44 $沃森生物(SZ300142)$周末,沃森和蓝鹊的m-RAN多价...
Polack, F. P. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.N. Engl. J. Med.383, 2603–2615 (2020). ArticleCASPubMedGoogle Scholar Halperin, S. A. et al. Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel ...
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine N Engl J Med, 383 (2020), pp. 2603-2615 CrossrefView in ScopusGoogle Scholar 22 Google Patents Procedure for detection of stress by segmentation and analyzing a heart beat signal https://patents.google.com/patent/US20050256414A1/en...
P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020). Article CAS PubMed Google Scholar Voysey, M. et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ...
Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine N Engl J Med, 383 (2020), pp. 2603-2615 CrossrefView in ScopusGoogle Scholar 2 A Harel Israel's ambitious vaccine drive is set for success as Netanyahu seeks election campaign boost. Haaretz https://www.haaretz.com/israel-news/...
结论:在中国人群中进行的 mRNA COVID-19疫苗的II期临床试验中,在接种BNT162b2疫苗后检测到强大的SARS-CoV-2中和抗体和强烈的SARS-CoV-2特异性T细胞反应。BNT162b2是安全的,并且在第二次给药后长达一个月的耐受性良好,表明中国成年人的风险-收益状况良好。链接:网页链接
P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020). Article CAS PubMed MATH Google Scholar Walsh, E. E. et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N. Engl. J. Med. 383, 2439–...
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine N Engl J Med, 383 (2020), pp. 2603-2615 CrossrefView in ScopusGoogle Scholar 6 MN Ramasamy, AM Minassian, KJ Ewer, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and...